Next-Microbiome
PrivateLast Round
Series A
Extension
Oct 21, 2025
Total Funding Raised
$56.52M
Company Overview
Next-Microbiome operates in Healthcare & Life Sciences and is based in Lafayette, California. Its latest recorded funding round was a Series A Extension round in October 2025.
Next-Microbiome is a biotechnology and wellness company that develops and markets scientifically-backed probiotic and prebiotic supplements designed to support gut health, metabolic function, and overall wellness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Next-Microbiome Comparables
Compare Next-Microbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cmbio | 81% | |
| OraSure Technologies Inc | 79% | |
| BaseClear B.V. | 78% |
For institutional investors. Book with your work email.
Next-Microbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 21, 2025 | ||||
| Series A | Jun 30, 2023 |
For institutional investors. Book with your work email.
Next-Microbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forepont Capital Partners | Series A Extension |
| UI Investissement | Series A, Series A Extension |
| Auriga Partners | Series A |
| Capital Grand Est | Series A |
| CE-Ventures | Series A |
| Biocodex | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2025
$3.3M round led by Biocodex.
For institutional investors. Book with your work email.
Next-Microbiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Next-Microbiome's valuation, stock price, and market status.
Is Next-Microbiome a public or private company?
Next-Microbiome is a private company.
What is the current stock price of Next-Microbiome?
Next-Microbiome is a private company, so its shares have no public market price. Caplight tracks Next-Microbiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Next-Microbiome worth (valuation)?
Valuation information for Next-Microbiome is not publicly available.
Can I buy Next-Microbiome stock?
Next-Microbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Next-Microbiome's last funding round?
Next-Microbiome's most recent funding round was Series A Extension on October 21, 2025.
Who are the main investors in Next-Microbiome?
Key investors in Next-Microbiome include CE-Ventures, Biocodex.
Will Next-Microbiome IPO soon?
No public IPO plans have been announced for Next-Microbiome.
How can I track Next-Microbiome secondary market activity?
Caplight tracks bids, offers, and trades in Next-Microbiome's shares on secondary markets.